Allied Market Research
Loading...
0
New
New
2021
Palliative Care Market

Palliative Care Market by Condition (Cardiovascular Diseases, Cancer, Chronic Respiratory Diseases, and Others), Age Group (Adult and Pediatric), and Provider (Hospitals & Clinics, Nursing Homes, and Others): Global Opportunity Analysis and Industry Forecast, 2021–2030

A05117
Pages: 208
Aug 2021 | 3661 Views
   
Author(s) : Sushant Terdale , Onkar Sumant
Tables: 124
Charts: 32
  • Formats*:

  • SIngle User License, Five User
    License & Enterprise User License

  • Data Pack Excel License

  • IComes with the additional cost
    of $2500.00 contact sales.

 

COVID-19

Pandemic disrupted the entire world and affected many industries.

Get detailed COVID-19 impact analysis on the Palliative Care Market

Request Now !

Palliative Care Market Overview:

The global palliative care market size was valued at $11,200 million in 2020, and is projected to reach $25,309 million by 2030, registering a CAGR of 8.4% from 2021 to 2030. Palliative care is an approach that increases the quality of life of patients and their families who are facing issues associated with life-threatening diseases. Palliative care services prevent & relieve suffering through early identification, correct assessment & treatment of pain, and other conditions such as physical, psychosocial or spiritual. Moreover, palliative care utilizes a team approach to support patients & their caregivers. This comprises addressing practical requirements and providing support system to aid patients live as actively as likely until death. Palliative care is essential for a wide range of chronic diseases such as cardiovascular diseases, cancer, chronic respiratory diseases, diabetes, kidney failure, chronic liver disease, and others.

Rise in geriatric population, increase in need of palliative care services in hospitals & clinics, surge in number of qualified physicians for palliative care, rise in public awareness of life-threatening diseases, adoption of sedentary lifestyle, increase in application of palliative care for homecare, and technological advancements for remote monitoring in the healthcare industry are the major factors that drive the growth of the palliative care market. In addition, rise in government funding in healthcare system, development of innovative therapies for chronic diseases, and favorable reimbursement from Medicaid and Medicare are other factors that further drive growth of the market. However, lack of access to palliative care services in underdeveloped countries is expected to hamper the market growth during the forecast period. Conversely, high palliative care market growth potential in emerging markets is expected to offer lucrative opportunities during the forecast period.

Palliative-Care-Market-2021-2030

Get more information on this report : Request Sample Pages

The World Health Organization (WHO) on January 30, 2020 declared COVID-19 outbreak a public health emergency of international concern. COVID-19 has affected around 210 countries across the globe. The workload for palliative care teams surged during the pandemic as most teams are small in number and different palliative care providers have complementary roles. The use of telemedicine in palliative care showed progresses in symptom management, care with comfort, and patient & family satisfaction. Moreover, telemedicine also simplified cooperation between the specialized palliative care team nurse and community nurses, which is useful parameter in COVID-19 pandemic. Thus, COVID-19 resulted in positive impact on the palliative care market.

Palliative Care Market Segmentation  

The palliative care market is segmented into condition, age group, provider, and region. On the basis of condition, the market is categorized into cardiovascular diseases, cancer, chronic respiratory diseases, and others. By age group, the market is bifurcated into adult and pediatric. The adult segment is further segmented into hospitals & clinics, nursing homes, and others. The pediatric segment is further segmented into hospitals & clinics, nursing homes, and others. On the basis of provider, the market is divided into hospitals & clinics, nursing homes, and others. Region-wise, the market is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

Segment review 

On the basis of condition, the cancer segment is the major revenue contributor, and is projected to grow significantly during the forecast period. Rise in geriatric population, surge in prevalence of cancer, early screening of the cancer, and rise in number of palliative care specialist for cancer treatment have significantly contributed toward the growth of the palliative care market. Moreover, technological advancements in remote monitoring in the healthcare industry and high potential of emerging economies are further expected to provide lucrative opportunities for market expansion. 

Palliative Care Market
By Condition

Your browser does not support the canvas element.

Cancer segment is projected as one of the most lucrative segment.

Get more information on this report : Request Sample Pages

By age group, the adult segment is the major shareholder in the palliative care market, owing to surge in need of palliative care in adult patients and adoption of sedentary lifestyle leading to increase in incidence of life-threatening diseases. Moreover, higher number of adult patients suffering from chronic diseases drives the growth of the adult segment. 

Palliative Care Market
By Provider

Your browser does not support the canvas element.

Hospitals and Clinics segment held a dominant position in 2020 and will continue to maintain the lead over the forecast period.

Get more information on this report : Request Sample Pages

Snapshot of Asia-Pacific palliative care market  

Asia-Pacific presents lucrative opportunities for key players operating in the palliative care market, owing to increase in number of initiatives and enhanced investments from governments for overall awareness on palliative care services and rise in demand for palliative care services. In addition, availability of advanced healthcare systems, rise in adoption of integrated palliative care in chronic life-threatening diseases treatment, surge in investments in equipping hospitals and palliative care centers with specialized palliative care teams, and significant surge in demand for advanced healthcare facilities contribute toward the growth of the market. Moreover, surge in focus of leading palliative care service providers on expanding their geographical presence in emerging Asia-Pacific countries to capture high market share is expected to drive the growth of the palliative care market in the region.  

Palliative Care Market
By Region

2030
North America 
Europe
Asia-pacific
Lamea

Asia-Pacific would exhibit the highest CAGR of 10.5% during 2021-2030.

Get more information on this report : Request Sample Pages

The key players profiled in this report include Amedisys, Inc., Chemed Corporation (Vitas Healthcare), Fillmore Capital Partners, LLC (Golden Living Centers/GGNSC Holdings LLC), Genesis HealthCare (Skilled Healthcare Group Inc.), Home Instead, Inc., Kindred Healthcare, LLC (Gentiva Health Services Inc.), Public Sector Pension Investment Board (Sunrise Senior Living Centers), Senior Care Centers of America, Inc, Seymour Health, and UCLA Health.

Key Benefits For Stakeholders

  • The study provides an in-depth analysis of the palliative care market along with the current trends and future estimations to elucidate the imminent investment pockets.
  • It offers palliative care market analysis from 2020 to 2030, which is expected to enable the stakeholders to capitalize on the prevailing opportunities in the market.
  • A comprehensive analysis of four regions is provided to determine the prevailing opportunities.
  • The profiles and growth strategies of the key players are thoroughly analyzed to understand the competitive outlook of the global palliative care market growth. 

Key Market Segments

By Condition

  • Cardiovascular Diseases
  • Cancer
  • Chronic Respiratory Diseases
  • Others

By Age Group

  • Adult 
    • Hospitals & Clinics
    • Nursing Homes
    • Others 
  • Pediatric
    • Hospitals & Clinics
    • Nursing Homes
    • Others

By Provider

  • Hospitals & Clinics
  • Nursing Homes
  • Others 

By Region

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • UK
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China 
    • India
    • Australia
    • South Korea
    • Rest of Asia-Pacific
  • LAMEA
    • Brazil
    • Saudi Arabia
    • South Africa
    • Rest of LAMEA
 

CHAPTER 1:INTRODUCTION

1.1.Report description 
1.2.Key Benefits for Stakeholders
1.3.Key market segments

1.3.1.List of key players profiled in the report

1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET LANDSCAPE

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top winning strategies

3.3.Porter’s five force analysis
3.4.Top player positioning, 2020
3.5.Market dynamics

3.5.1.Drivers

3.5.1.1.Rise in incidence of life-threatening diseases
3.5.1.2.Increase in geriatric population
3.5.1.3.Increase in government expenditure on healthcare

3.5.2.Restraint

3.5.2.1.lack of access to palliative care services in underdeveloped countries

3.5.3.Opportunities

3.5.3.1.High market growth potential in emerging markets

3.5.4.Impact analysis

3.6.Covid-19 Impact analysis on palliative care market

CHAPTER 4:PALLIATIVE CARE MARKET, BY CONDITION

4.1.Overview

4.1.1.Market size and forecast

4.2.Cardiovascular diseases

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Cancer

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Chronic respiratory diseases

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

4.5.Others

4.5.1.Key market trends, growth factors, and opportunities
4.5.2.Market size and forecast, by region
4.5.3.Market analysis, by country

CHAPTER 5:PALLIATIVE CARE MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.Adults

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.2.3.Market size and forecast, by provider

5.3.Pediatric

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
5.3.3.Market size and forecast, by provider

CHAPTER 6:PALLIATIVE CARE MARKET, BY PROVIDER

6.1.Overview

6.1.1.Market size and forecast

6.2.Hospitals & clinics

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Nursing homes

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Others

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:PALLIATIVE CARE MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.Market size and forecast, by country

7.2.2.1.U.S.

7.2.2.1.1.U.S. palliative care market, by condition
7.2.2.1.2.U.S. palliative care market, by age group
7.2.2.1.3.U.S. palliative care market, by provider

7.2.2.2.Canada

7.2.2.2.1.Canada palliative care market, by condition
7.2.2.2.2.Canada palliative care market, by age group
7.2.2.2.3.Canada palliative care market, by provider

7.2.2.3.Mexico

7.2.2.3.1.Mexico palliative care market, by condition
7.2.2.3.2.Mexico palliative care market, by age group
7.2.2.3.3.Mexico palliative care market, by provider

7.2.3.North America market size and forecast, by condition
7.2.4.North America market size and forecast, by age group
7.2.5.North America market size and forecast, by provider

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Market size and forecast, by country

7.3.2.1.Germany

7.3.2.1.1.Germany palliative care market, by condition
7.3.2.1.2.Germany palliative care market, by age group
7.3.2.1.3.Germany palliative care market, by provider

7.3.2.2.France

7.3.2.2.1.France palliative care market, by condition
7.3.2.2.2.France palliative care market, by age group
7.3.2.2.3.France palliative care market, by provider

7.3.2.3.UK

7.3.2.3.1.UK palliative care market, by condition
7.3.2.3.2.UK palliative care market, by age group
7.3.2.3.3.UK palliative care market, by provider

7.3.2.4.Italy

7.3.2.4.1.Italy palliative care market, by condition
7.3.2.4.2.Italy palliative care market, by age group
7.3.2.4.3.Italy palliative care market, by provider

7.3.2.5.Spain

7.3.2.5.1.Spain palliative care market, by condition
7.3.2.5.2.Spain palliative care market, by age group
7.3.2.5.3.Spain palliative care market, by provider

7.3.2.6.Rest of Europe

7.3.2.6.1.Rest of Europe palliative care market, by condition
7.3.2.6.2.Rest of Europe palliative care market, by age group
7.3.2.6.3.Rest of Europe palliative care market, by provider

7.3.3.Europe market size and forecast, by condition
7.3.4.Europe market size and forecast, by age group
7.3.5.Europe market size and forecast, by provider

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Market size and forecast, by country

7.4.2.1.Japan

7.4.2.1.1.Japan palliative care market, by condition
7.4.2.1.2.Japan palliative care market, by age group
7.4.2.1.3.Japan palliative care market, by provider

7.4.2.2.China

7.4.2.2.1.China palliative care market, by condition
7.4.2.2.2.China palliative care market, by age group
7.4.2.2.3.China palliative care market, by provider

7.4.2.3.Australia

7.4.2.3.1.Australia palliative care market, by condition
7.4.2.3.2.Australia palliative care market, by age group
7.4.2.3.3.Australia palliative care market, by provider

7.4.2.4.India

7.4.2.4.1.India palliative care market, by condition
7.4.2.4.2.India palliative care market, by age group
7.4.2.4.3.India palliative care market, by provider

7.4.2.5.South Korea

7.4.2.5.1.South Korea palliative care market, by condition
7.4.2.5.2.South Korea palliative care market, by age group
7.4.2.5.3.South Korea palliative care market, by provider

7.4.2.6.Rest of Asia-Pacific

7.4.2.6.1.Rest of Asia-Pacific palliative care market, by condition
7.4.2.6.2.Rest of Asia-Pacific palliative care market, by age group
7.4.2.6.3.Rest of Asia-Pacific palliative care market, by provider

7.4.3.Asia-Pacific market size and forecast, by condition
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific market size and forecast, by provider

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.Market size and forecast, by country

7.5.2.1.Brazil

7.5.2.1.1.Brazil palliative care market, by condition
7.5.2.1.2.Brazil palliative care market, by age group
7.5.2.1.3.Brazil palliative care market, by provider

7.5.2.2.Saudi Arabia

7.5.2.2.1.Saudi Arabia palliative care market, by condition
7.5.2.2.2.Saudi Arabia palliative care market, by age group
7.5.2.2.3.Saudi Arabia palliative care market, by provider

7.5.2.3.South Africa

7.5.2.3.1.South Africa palliative care market, by condition
7.5.2.3.2.South Africa palliative care market, by age group
7.5.2.3.3.South Africa palliative care market, by provider

7.5.2.4.Rest of LAMEA

7.5.2.4.1.Rest of LAMEA palliative care market, by condition
7.5.2.4.2.Rest of LAMEA palliative care market, by age group
7.5.2.4.3.Rest of LAMEA palliative care market, by provider

7.5.3.LAMEA market size and forecast, by condition
7.5.4.LAMEA market size and forecast, by age group
7.5.5.LAMEA market size and forecast, by provider

CHAPTER 8:COMPANY PROFILES

8.1.Amedisys, Inc.

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Chemed Corporation (Vitas Healthcare)

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio
8.2.5.Business performance
8.2.6.Key strategic moves and developments

8.3.Fillmore Capital Partners, LLC (Golden Living Centers/GGNSC Holdings LLC)

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio

8.4.Genesis HealthCare (Skilled Healthcare Group Inc.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.Home Instead, Inc.

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Key strategic moves and developments

8.6.Kindred Healthcare, LLC (Gentiva Health Services Inc.)

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Key strategic moves and developments

8.7.Public Sector Pension Investment Board (Sunrise Senior Living Centers)

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.SENIOR CARE CENTERS OF AMERICA, INC

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Key strategic moves and developments

8.9.Seymour Health

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.University of California (UCLA Health)

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance

LIST OF TABLES

TABLE 01.PALLIATIVE CARE MARKET, BY CONDITION, 2020-2030 ($MILLION)
TABLE 02.PALLIATIVE CARE MARKET FOR CARDIOVASCULAR DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 03.PALLIATIVE CARE MARKET FOR CANCER, BY REGION, 2020-2030 ($MILLION)
TABLE 04.PALLIATIVE CARE MARKET FOR CHRONIC RESPIRATORY DISEASES, BY REGION, 2020-2030 ($MILLION)
TABLE 05.PALLIATIVE CARE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 06.PALLIATIVE CARE MARKET, BY AGE GROUP, 2020-2030 ($MILLION)
TABLE 07.PALLIATIVE CARE MARKET FOR ADULTS, BY REGION, 2020-2030 ($MILLION)
TABLE 08.PALLIATIVE CARE MARKET FOR ADULTS, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 09.PALLIATIVE CARE MARKET FOR PEDIATRIC, BY REGION, 2020-2030 ($MILLION)
TABLE 10.PALLIATIVE CARE MARKET FOR PEDIATRIC, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 11.PALLIATIVE CARE MARKET, BY PROVIDER, 2020-2030 ($MILLION)
TABLE 12.PALLIATIVE CARE MARKET FOR HOSPITALS & CLINICS, BY REGION, 2020-2030 ($MILLION)
TABLE 13.PALLIATIVE CARE MARKET FOR NURSING HOMES, BY REGION, 2020-2030 ($MILLION)
TABLE 14.PALLIATIVE CARE MARKET FOR OTHERS, BY REGION, 2020-2030 ($MILLION)
TABLE 15.PALLIATIVE CARE MARKET, BY REGION, 2020–2030 ($MILLION)
TABLE 16.NORTH AMERICA PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 17.U.S. PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 18.U.S. PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 19.U.S. PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 20.CANADA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 21.CANADA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 22.CANADA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 23.MEXICO PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 24.MEXICO PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 25.MEXICO PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 26.NORTH AMERICA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 27.NORTH AMERICA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 28.NORTH AMERICA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 29.EUROPE PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 30.GERMANY PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 31.GERMANY PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 32.GERMANY PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 33.FRANCE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 34.FRANCE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 35.FRANCE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 36.UK PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 37.UK PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 38.UK PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 39.ITALY PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 40.ITALY PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 41.ITALY PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 42.SPAIN PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 43.SPAIN PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 44.SPAIN PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 45.REST OF EUROPE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 46.REST OF EUROPE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 47.REST OF EUROPE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 48.EUROPE PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 49.EUROPE PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 50.EUROPE PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 51.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 52.JAPAN PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 53.JAPAN PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 54.JAPAN PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 55.CHINA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 56.CHINA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 57.CHINA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 58.AUSTRALIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 59.AUSTRALIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 60.AUSTRALIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 61.INDIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 62.INDIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 63.INDIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 64.SOUTH KOREA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 65.SOUTH KOREA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 66.SOUTH KOREA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 67.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 68.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 69.REST OF ASIA-PACIFIC PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 70.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 71.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 72.ASIA-PACIFIC PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 73.LAMEA PALLIATIVE CARE MARKET, BY COUNTRY, 2020–2030 ($MILLION)
TABLE 74.BRAZIL PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 75.BRAZIL PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 76.BRAZIL PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 77.SAUDI ARABIA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 78.SAUDI ARABIA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 79.SAUDI ARABIA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 80.SOUTH AFRICA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 81.SOUTH AFRICA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 82.SOUTH AFRICA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 83.REST OF LAMEA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 84.REST OF LAMEA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 85.REST OF LAMEA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 86.LAMEA PALLIATIVE CARE MARKET, BY CONDITION, 2020–2030 ($MILLION)
TABLE 87.LAMEA PALLIATIVE CARE MARKET, BY AGE GROUP, 2020–2030 ($MILLION)
TABLE 88.LAMEA PALLIATIVE CARE MARKET, BY PROVIDER, 2020–2030 ($MILLION)
TABLE 89.AMEDISYS: COMPANY SNAPSHOT
TABLE 90.AMEDISYS: OPERATING SEGMENTS
TABLE 91.AMEDISYS: PRODUCT PORTFOLIO
TABLE 92.AMEDISYS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 93.CHEMED: COMPANY SNAPSHOT
TABLE 94.CHEMED: OPERATING SEGMENTS
TABLE 95.CHEMED: PRODUCT PORTFOLIO
TABLE 96.CHEMED: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 97.FCP: COMPANY SNAPSHOT
TABLE 98.FCP: OERATING SEGMENT
TABLE 99.FCP: PRODUCT PORTFOLIO
TABLE 100.GENESIS: COMPANY SNAPSHOT
TABLE 101.GENESIS: OPERATING SEGMENTS
TABLE 102.GENESIS: PRODUCT PORTFOLIO
TABLE 103.HOME INSTEAD: COMPANY SNAPSHOT
TABLE 104.HOME INSTEAD: OERATING SEGMENT
TABLE 105.HOME INSTEAD.: PRODUCT PORTFOLIO
TABLE 106.HOME INSTEAD: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 107.KINDRED HEALTHCARE: COMPANY SNAPSHOT
TABLE 108.KINDRED HEALTHCARE: OPERATING SEGMENTS
TABLE 109.KINDRED HEALTHCARE: PRODUCT PORTFOLIO
TABLE 110.KINDRED HEALTHCARE: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 111.PSP INVESTMENTS: COMPANY SNAPSHOT
TABLE 112.PSP INVESTMENTS: OPERATING SEGMENTS
TABLE 113.PSP INVESTMENTS: PRODUCT PORTFOLIO
TABLE 114.PSP INVESTMENTS: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 115.SENIOR CARE CENTERS OF AMERICA: COMPANY SNAPSHOT
TABLE 116.SENIOR CARE CENTERS OF AMERICA: OERATING SEGMENT
TABLE 117.SENIOR CARE CENTERS OF AMERICA: PRODUCT PORTFOLIO
TABLE 118.SENIOR CARE CENTERS OF AMERICA: KEY STRATEGIC MOVES AND DEVELOPMENTS
TABLE 119.SEYMOUR: COMPANY SNAPSHOT
TABLE 120.SEYMOUR: OPERATING SEGMENTS
TABLE 121.SEYMOUR: PRODUCT PORTFOLIO
TABLE 122.UC: COMPANY SNAPSHOT
TABLE 123.UC: OPERATING SEGMENTS
TABLE 124.UC: PRODUCT PORTFOLIO

LIST OF FIGURES

FIGURE 01.PALLIATIVE CARE MARKET SEGMENTATION
FIGURE 02.TOP INVESTMENT POCKETS
FIGURE 03.TOP WINNING STRATEGIES, BY YEAR, 2018-2021
FIGURE 04.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2018-2021
FIGURE 05.TOP WINNING STRATEGIES, BY COMPANY, 2018-2021
FIGURE 06.MODERATE BARGAINING POWER OF SUPPLIERS
FIGURE 07.LOW BARGAINING POWER OF BUYERS
FIGURE 08.MODERATE THREAT OF SUBSTITUTES
FIGURE 09.HIGH THREAT OF NEW ENTRANTS
FIGURE 10.MODERATE INTENSITY OF RIVALRY
FIGURE 11.TOP PLAYER POSITIONING, 2020
FIGURE 12.IMPACT ANALYSIS
FIGURE 13.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR CARDIOVASCULAR DISEASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 14.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR CANCER, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 15.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR CHRONIC RESPIRATORY DISEASES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 16.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 17.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR ADULTS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 18.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR PEDIATRIC, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 19.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR HOSPITALS & CLINICS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 20.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR NURSING HOMES, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 21.COMPARATIVE ANALYSIS OF PALLIATIVE CARE MARKET FOR OTHERS, BY COUNTRY, 2020 & 2030 ($MILLION)
FIGURE 22.AMEDISYS: NET SALES, 2018–2020 ($MILLION)
FIGURE 23.AMEDISYS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 24.CHEMED: NET SALES, 2019–2021 ($MILLION)
FIGURE 25.CHEMED: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 26.GENESIS: NET SALES, 2018–2020 ($MILLION)
FIGURE 27.GENESIS: REVENUE SHARE BY SEGMENT, 2020 (%)
FIGURE 28.PSP INVESTMENTS: NET SALES, 2019–2021 ($MILLION)
FIGURE 29.PSP INVESTMENTS: REVENUE SHARE BY SEGMENT, 2021 (%)
FIGURE 30.PSP INVESTMENTS: REVENUE SHARE BY REGION, 2021 (%)
FIGURE 31.SEYMOUR: NET SALES, 2018–2020 ($MILLION)
FIGURE 32.UC: NET SALES, 2018–2020 ($MILLION)

 
 

Palliative care serves as a health care specialty that includes a philosophy of care and a structured system for providing care to the patients with severe or enervating diseases from diagnosis till death.

Increase in chronic life-threatening diseases, including cardiovascular diseases, cancer, neurological diseases, diabetes, and other chronic diseases worldwide notably contributes toward the market growth. In addition, adoption of smoking, higher exposure to toxic materials, and adverse climate conditions & air pollution causing cancer will help the market gain traction during the forecast period. Moreover, surge in number of hospitals & clinics with advanced palliative care services and rise in demand for palliative care specialist further boost the growth of the market. However, lack of access to palliative care services in underdeveloped countries is expected to hamper the market growth during the forecast period.  

PURCHASE OPTIONS

Start reading instantly ,This Report and over 13000+ thousand more Reports, Available with Avenue Library, T&C*

Call or Email us

U.S.-Canada
Toll-free :
+1-800-792-5285
Int'l : +1-503-894-6022
Europe : + 44-845-528-1300
Email : help@alliedmarketresearch.com
FREQUENTLY ASKED QUESTIONS?
Our Report Looks Like This
 

A. The total market value of Palliative Care market is $11,200.0 million in 2020.

A. The forcast period for Palliative Care market is 2021 to 2030

A. The market value of Palliative Care market in 2021 is $12,196.8 million.

A. The base year is 2020 in Palliative Care market

A. Top companies such as Genesis HealthCare (Skilled Healthcare Group Inc.), Amedisys, Inc., Chemed Corporation (Vitas Healthcare), Home Instead, Inc., Kindred Healthcare, LLC (Gentiva Health Services Inc.), Seymour Health, and Senior Care Centers of America, Inc. held a high market position in 2020. These key players held a high market postion owing to the strong geographical foothold in different regions.

A. Cancer segment is the most influencing segment owing to rise in geriatric population, surge in prevalence of cancer, early screening of the cancer, and rise in number of palliative care specialist for cancer treatment have significantly contributed toward the growth of the market. Moreover, technological advancements in remote monitoring in the healthcare industry and high potential of emerging economies are further expected to provide lucrative opportunities for market expansion.

A. Rise in geriatric population, increase in need of palliative care services in hospitals & clinics, surge in number of qualified physicians for palliative care, rise in public awareness of life-threatening diseases, adoption of sedentary lifestyle, increase in application of palliative care for homecare, and technological advancements for remote monitoring in the healthcare industry are the major factors that drive the growth of the market.

A. Asia-Pacific has the highest growth rate in the market which is growing due to increase in number of initiatives and enhanced investments from governments for overall awareness on palliative care services and rise in demand for palliative care services. In addition, availability of advanced healthcare systems, rise in adoption of integrated palliative care in chronic life-threatening diseases treatment, surge in investments in equipping hospitals and palliative care centers with specialized palliative care teams, and significant surge in demand for advanced healthcare facilities contribute toward the growth of the market.

A. Palliative care is an approach that increases the quality of life of patients and their families who are facing issues associated with life-threatening diseases

A. Palliative care serves as a health care specialty that includes a philosophy of care and a structured system for providing care to the patients with severe or enervating diseases from diagnosis till death

Allied Market Research Allied Market Research Allied Market Research
RELATED TAGS
 

HAVE QUESTIONS?
SPEAK WITH ANALYST

 

DID YOU MISS ANYTHING?
DO YOU HAVE SPECIFIC REQUIREMENTS?

 

Download Sample

OR

Purchase Full Report of
Palliative Care Market

Start reading instantly.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.

  • Online Only
  • $3,712
  • Online cloud access only
  • Restricted print, copy, paste & download
  • Read only
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Data Pack
  • $4,125
  • Restricted to one authorized user
  • One print only
  • Available in
    Excel
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Single User
  • $6,168
  • Restricted to one authorized user
  • One print only
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Five Users
  • $6,929
  • Limited to five authorized users
  • Print upto five copies
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Enterprise
    License/PDF

  • $10,663
  • Unlimited
    within
    company/enterprise
  • Available in Excel & PDF
  •   Free quarterly industry update
  •   Free report update (Within 180 days)
  •   Subscription model sign in
  • Library Membership
  • $ 699/mo
  • Published Content
    E-access
  • Company Profiles
    E-access
  • Newly Added Content Access
  • 10 PDF
    Downloads
  • 5 Excel Data
    Pack Downloads
  • 250 Company Profiles PDF Downloads
  • Buy Now

*Taxes/Fees, if applicable will be added during checkout. All prices in USD

 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers

 
 

Featured Reports

 

Erythropoietin Drugs Market

Global Opportunity Analysis and Industry Forecast, 2021–2028

Published in May 2021

Download Sample

Protein Therapeutics Market

Global Opportunity Analysis and Industry Forecast, 2017-2023

Published in Nov 2017

Download Sample

Surgical Equipment Market

Global Opportunity Analysis and Industry Forecast, 2020-2027

Published in Jan 2021

Download Sample

Medical Implant Market

Global Opportunity Analysis and Industry Forecast, 2020–2027

Published in Nov 2020

Download Sample

Featured Readings

 

Get fresh content delivered

Get insights on topics that are crucial for your business. Stay abreast of your interest areas.

 
Get Industry Data Alerts
 

Why Allied Market Research?

 

Infallible Methodology

To ensure high-level data integrity, accurate analysis, and impeccable forecasts

Analyst Support

For complete satisfaction

Customization

On-demand customization of scope of the report to exactly meet your needs

TARGETED MARKET VIEW

Targeted market view to provide pertinent information and save time of readers